Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04358185
Title Itacitinib in Advanced Hepatocellular Carcinoma (JAKaL)
Acronym JAKaL
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Imperial College London
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR


No variant requirements are available.